Conor Hale is a Senior Editor at FierceMedTech and FierceBiotech. He specializes in reporting on medical developments, with a focus on oncology, pancreatic cancer research, and digital health, while also covering pharmaceutical regulation and remote healthcare. Conor's work has been featured in Biotech, NewsBreak, and Fierce Pharma.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Conor Hale's coverage is heavily focused on medical technology, healthcare, FDA approvals, and biotechnology. His articles often cite data and press releases from the private sector. He frequently covers stories related to new product launches, regulatory issues in the healthcare industry, and advancements in medical technology.
To effectively reach out to Conor Hale regarding potential article ideas or pitches, consider offering exclusive access to experts who can provide insights into emerging trends in medical technology and healthcare. Additionally, sources with deep knowledge of FDA approval processes or those involved in innovative AI applications within the healthcare sector may be of interest to him.
As he does not have a specified geographic focus but covers global developments in the industry without regional limitations.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Helium is essential to running an MRI machine. While the inert gas has always been subject to a somewhat volatile market, prices have been upended
By: Conor Hale
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging geography in the heart, for
Following its curtain-raising at last fall's meeting of the Radiological Society of North America, GE HealthCare has obtained an FDA clearance for its photon-counting CT system.
Endogenex has raised $50 million in venture capital financing to complete the development of its minimally invasive procedure for Type 2 diabetes and bring its tech to the FDA.
Philips has secured an FDA clearance for its artificial intelligence program that tracks and guides the placement of a minimally invasive heart valve implant in real time.
Following an FDA green light last December for its upgraded robot, CMR Surgical has begun rolling out its Versius Plus platform to the U.S.
By: Conor Hale
After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical data for its electric field-based treatment in metastatic cases of the aggressive disease.
By: Conor Hale
In one of the largest studies of its kind, a trial of Boston Scientific's small, permanent cardiac implant showed that it could potentially serve
By: Conor Hale
Two separate randomized trials of Johnson & Johnson's miniaturized Impella heart pumps failed to illustrate the devices' benefits, spanning specific
Smith+Nephew (LON: SN, NYSE: SNN) CFO John Rogers plans to step down from his post at the British ortho and sports medicine tech giant to become EVP and CF
